In an effort to work proactively against drug shortages, the FDA is setting new rules requiring companies to notify the agency of any manufacturing interruptions of drugs in short supply.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303843104579168103120586352.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303843104579168103120586352.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento